Arena Pharmaceuticals Inc. (ARNA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Arena Pharmaceuticals Inc...

NASDAQ: ARNA · Real-Time Price · USD
99.99
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Arena Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-616.43M -582.99M -484.11M -422.94M
Depreciation & Amortization
3.87M 3.88M 3.88M 3.88M
Stock-Based Compensation
70.37M 72.26M 67.27M 61.72M
Other Working Capital
9.78M 8.92M 29.52M -6.1M
Other Non-Cash Items
66.99M 52.99M -18.76M -21.51M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
23.18M 15.96M 36.6M -192K
Operating Cash Flow
-452.02M -437.9M -395.12M -379.04M
Capital Expenditures
-70.99M -70.59M -560K -385K
Cash Acquisitions
70M 70M n/a n/a
Purchase of Investments
-612.22M -802.54M -841.62M -1.01B
Sales Maturities Of Investments
1B 1.1B 1.06B 1.18B
Other Investing Acitivies
-70M -71M -1M -1M
Investing Cash Flow
321.4M 225.61M 215.29M 166.8M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
135.41M 138.68M 143.74M 454.69M
Financial Cash Flow
135.41M 138.68M 143.74M 454.69M
Net Cash Flow
5.03M -73.49M -36M 242.55M
Free Cash Flow
-523M -508.49M -395.68M -379.42M